WHO labels JN.1 COVID-19 Strain As 'Variant Of Interest', Cautions For Monitoring

The World Health Organization (WHO) on Tuesday classified the JN.1 strain of COVID-19 as a "variant of interest," yet affirmed it posed no significant threat to public health. Previously grouped as a variant within the BA.2.86 lineage, JN.1's global public health risk was evaluated as low based on current evidence, according to the WHO.

The WHO assured that existing vaccines remain effective in shielding against severe illness or fatalities caused by the new variant JN.1 and other prevalent COVID-19 strains. Stressing the virus's evolutionary nature, the WHO urged member states to continue sharing virus sequence data and maintain robust surveillance.

Dr. @mvankerkhove from the WHO addressed the surge in respiratory diseases including COVID-19 and the JN.1 subvariant, underscoring ongoing WHO evaluations. Their advice emphasized following public health protocols to safeguard loved ones during the holiday season.

In the United States, the Centers for Disease Control and Prevention (CDC) estimated that the JN.1 subvariant accounted for 15% to 29% of cases by December 8. The agency clarified that there's currently no evidence suggesting JN.1 poses a higher public health risk compared to other circulating variants, highlighting the importance of an updated vaccine for continued protection.

Initially identified in September in the US, the JN.1 variant has been observed in seven cases in China. Additionally, the variant was detected in Kerala, India, prompting governmental advisories to implement necessary health measures, especially during the upcoming festive season, emphasizing respiratory hygiene practices to mitigate transmission risks.